Skip to content

Transvaginal ovarian drilling improves ovarian response in poor responders with polycystic ovary syndrome undergoing IVF

Improvement of ovarian response via transvaginal ovarian drilling in poor ovarian patients with polycystic ovary syndrome undergoing in vitro fertilization-prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023612
Enrollment
Unknown
Registered
2019-06-04
Start date
2016-01-01
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

1:Transvaginal ovarian drilling
2:small follicle drilling on the ovum pick-up

Sponsors

Reproductive Medical Center of Ruijin Hospital School of Medicine, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: We enrolled women who were diagnosed with PCOS based on the presence of all the Rotterdam criteria: 1. oligo- or amenorrhea (cycle>35 days); 2. bio-chemical/clinical hyperandrogenism (defined as a Ferriman-Gallwey score of =8, testosterone >2.5 nmol/l, and/or androstenedione >9.0 nmol/l); and 3. polycystic ovarian morphology (=12 follicles [2–9 mm] in at least 1 ovary). Patients with hyperinsulinemia were administered metformin for 2–3 months to decrease the insulin levels to normal levels. These patients were categorized into 3 groups: 1) poor responders (no or 15 dominant follicles developed within 2 weeks of stimulation, with the E2 level > 4200 pg/ml on the trigger day).

Exclusion criteria

Exclusion criteria: Previous ovarian surgery and co-existing endocrine diseases (diabetes mellitus, estrogen-dependent tumors, thyroid disease, Cushings syndrome, or congenital adrenal hyperplasia).

Design outcomes

Primary

MeasureTime frame
ovarian respone;Pregnancy outcome;hormone levels;

Secondary

MeasureTime frame
Demographic clinical characteristics;

Countries

China

Contacts

Public ContactBufang Xu

Reproductive Medical Center of Ruijin Hospital School of Medicine, Shanghai Jiao Tong University

bufangxu@163.com+86 02164370045-601700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026